搜索
新闻媒体
Your location:
Homepage
-
News Media
08-31

Newsletter Issue 0901

From August 28 to August 31, 2021, Chen Yuanfu, Executive Deputy Dean of the Institute of Oxygen Supply of Tibet University, Li Yong, Deputy Dean, Lu Wanbo, Deputy Dean of the Everest Research Institute and Deputy Dean of the School of Finance and Economics of Tibet University, went to Ali Regional investigation of the oxygen supply in the plateau. The company’s chairman Lu Qizhong and sales director Mu Cheng accompanied the investigation. During the investigation, they went to the centralized oxygen supply land in Burang County, Zanda County, and Ritu County in Ngari Prefecture. A detailed understanding of the staffing and oxygen use situation.
08-28

Newsletter 01

On August 28, 2021, Chen Yongqi, member of the Standing Committee of the Party Committee of the Tibet Autonomous Region and Minister of the Organization Department, accompanied by Chairman Lv Xinmin of the Ali Region CPPCC and Yang Hui, Secretary of the County Party Committee of Gar County, came to our company to investigate the situation of centralized oxygen supply in Ali. The chairman of the company, Lu Zhong, reported to the research team on the operation of Ouwei Group since its establishment, and introduced the number of personnel, the company's service mode and the operation of equipment. Has been fully recognized by the research team. As shown below
08-19

After the withdrawal of the order, Yitu Technology may sell its medical business. How difficult is it to commercialize AI medical care?

On August 11, according to ti media reports, Beijing Shengrui Bolian Technology Co., LTD. (hereinafter referred to as "Shengrui Medical") has completed the acquisition of Shanghai Yitu Network Technology Co., LTD. (hereinafter referred to as "Yitu Technology") of the medical business segment, but the purchase price and other circumstances are unknown. According to a report in the 21st century economy, according to the figure of science and technology announced as early as in 2016, the second half of the medical market, but according to the figure the medical business is not good good box office of science and technology, although technology obtained high praise but marketing difficult, according to several media reports, in the first half of 2021, failed to listed according to the figure of science and technology had layoffs, layoffs or up to 70% medical business. The main business of shengrui medical is similar to that of yitu technology medical sector. It also provides ai-based and internet-based medical solutions for various medical service institutions. According to tianyan APP, shengrui medical has completed six rounds of financing, the last of which was the C++ round of financing completed in May 2021. Although details and reasons for the acquisition were not disclosed, the reason yitu is selling its healthcare business may have something to do with its chronic losses. From 2017 to the first half of 2020, Yitu Technology achieved a net loss of 1.166 billion yuan, 1.161 billion yuan, 3.642 billion yuan and 1.30 billion yuan respectively. The net outflow of cash flow generated by operating activities was 235 million yuan, 677 million yuan, 1.119 billion yuan and 581 million yuan respectively.
08-19

Biofourmis, a medical technology startup, receives US$100 million in Series C financing, led by the second phase of the SoftBank Vision Fund

As one of the emerging companies favored by venture capital, Biofourmis hopes to enhance traditional medicine through digital technology (including wearable devices and software). The so-called digital technology combined with traditional hospitals refers to adding personalized medicines to help ensure that the right patients can get the right medicines at the right time. By tracking the patient’s condition outside the hospital, the doctor may suggest changes to the dosage or use of other drug combinations. In theory, this technology is attractive to pharmaceutical companies looking to improve the efficacy of expensive specialty drugs. This field is called "digital therapy", and research companies estimate that its value may exceed $9.6 billion by 2026. This also represents a larger trend, that is, digital technology enters the healthcare industry. In the United States alone, the value of the healthcare sector exceeds US$3.5 trillion. Now, Biofourmis will receive a US$100 million capital injection in a Series C financing led by the SoftBank Vision Fund Phase 2, and existing investors including Sequoia Capital will follow suit. Kuldeep Singh Rajput, chief administrative officer of Biofourmis, said the company has conducted a number of clinical studies showing that wearable devices can help clinicians predict heart failure events several weeks in advance and intervene before then. At present, heart failure is the main area of ​​concern, although the company has increasingly set foot in other disease areas. In the United States, 6.5 million people suffer from heart failure, which makes the management cost of the healthcare system more than 30 billion U.S. dollars. It is also one of the main causes of death. The company said it is also involved in other areas such as chronic pain, oncology and Covid-19. It also hopes to expand its scale by selling its services to the health system to help patients monitor them after they are discharged from the hospital. In the United States, if the patient’s 30-day readmission rate is higher than expected after being discharged from the hospital for reasons such as pneumonia and heart failure, the hospital system will be punished.
08-19

In the first half of 2021, medical investment and financing hit a three-year high, and Internet capital accelerates scientific and technological medical investment

Medical technology has been a particularly hot industry in recent years. With the improvement of people's living standard and the constant change of people's concept, people now pay more and more attention to medical health. There are quite a few people, willing to pay a higher price, to buy their own health. Meanwhile, another problem keeps cropping up. Due to the great changes in the environment, people are more and more prone to some diseases, such as diabetes, leukaemia and so on. The treatment of these diseases, need to invest a large amount of research costs, to make continuous technological progress. Therefore, in recent years, medical technology and the medical industry has been a relatively hot circle. Where there is demand, there will be a market, and where there is a market, there will be production and investment. It is people's high attention to medical care that has formed a huge demand market. Many investors have found this and are more willing to invest in the medical industry. China's medical investment and financing hit a three-year high in the first half of this year. First, the boom in investment In fact, in recent years, there are many large enterprises, they pay more attention to the medical industry. And in the first half of this year, there is a boom. According to reliable information statistics, Sequoia Capital investment in the medical field has nearly exceeded ten. And its investment, is not the traditional medical industry, but today's hottest new medical industry. Medical treatment seems to be increasingly linked to science and technology. With the development of science and technology, more and more medical industries have emerged such as biopharmaceutical and AI medical treatment, which also represent a new direction of the medical industry. In addition to these large investment institutions pay special attention to the medical industry, some industrial companies also have a strong interest in the medical industry.
Previous page
1

Contact

Address: Kunlun Avenue, Gaer County, Ali District, Tibet Autonomous Region

Online message

Username used for comment:
Customer message
Description:
验证码

Alway Technology Group

Alway Technology Group

    Mobile website

Alway Technology Group

Website Official Account